Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
6
×
life sciences
national blog main
boston
clinical trials
fda
deals
investing
national top stories
biotech ipos
medical device
san francisco blog main
san francisco top stories
startups
ulcerative colitis
venture capital
20/20 healthcare partners
480 biomedical
acute myeloid leukemia
ally bridge group
alx oncology
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
arsenal medical
autoimmune diseases
berkeley lights
big data analytics
biofourmis
biovotion
blackrock
bob langer
cancer drugs
cancer immunotherapy
casdin capital
cd47
christian angermayer
chronic kidney disease
What
raised
6
×
ipo
million
new
biotech
company
therapeutics
companies
develop
developing
diseases
drug
genetic
medicines
raises
treat
analysis
analytics
arrival
associated
bio
biofourmis
bring
brings
data
days
debut
device
devices
dialysis
digital
disease
disorders
drugs
dyne
dyne’s
employing
employs
enclear
globally
Language
unset
6
×
Current search:
unset
×
raised
×
" boston top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device